Still, I kind of agree with your SOC arm argument. Why force patients on Avastin? It is used with success to control edema, improve progression free survival, and limit steroid use.... all of which are important uses in rGBM.
But your post doesn't jive with the results of the limited and continuous cohorts in the phase II rGBM trial.
As to the failure of Avastin makes rGBM more lethal. Tumors build resistance to Avastin's mechanism of action with time, leading to failure to Avastin. Considering rGBM, It's pretty lethal to begin with with horrific median survivorship. Optune, vaccines, steroids, Avastin and VB-111.... EVERYTHING fails in time. The goal with VB-111 is to test the thesis that controlling tumor volume for longer periods of time, attenuating tumor growth will increase overall survival. If you can increase overall survival from 8-9 months to over a year, it doesn't sound like much, but it is a very big deal.
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM